Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-04 8:45 pm Sale | 2024-08-30 | 13D | Tango Therapeutics, Inc. TNGX | Third Rock Ventures IV L.P. | 17,001,475 15.900% | -2,362,500 (-12.20%) | Filing History |
| 2024-02-14 4:15 pm Unchanged | 2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH | Third Rock Ventures IV L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:53 pm Purchase | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Third Rock Ventures IV L.P. | 6,758,204 11.500% | 6,758,204 (New Position) | Filing History |
| 2021-08-19 4:35 pm Purchase | 2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX | Third Rock Ventures IV L.P. | 19,363,975 22.100% | 19,363,975 (New Position) | Filing History |
| 2020-02-05 4:33 pm Purchase | 2019-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Third Rock Ventures IV L.P. | 2,343,154 10.000% | 2,343,154 (New Position) | Filing History |